Actron OBD II scan tool review shows functionality for vehicle diagnostics. China issues new Greenland warning to Trump ...

During the last week, Cathie Wood’s ARK Invest reported strong buying in biotech, genomics, and deep-tech names across its various funds while reducing exposure in diagnostics, software chips, and ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

FRANKFURT, Nov 17 (Reuters) - Siemens Healthineers (SHLG.DE), opens new tab is considering divesting or spinning off its diagnostics division by 2030 after restructuring the division but has not yet ...

Co-Diagnostics, Inc. (NASDAQ:CODX) shares are trading higher Monday after the company signed a definitive agreement with Arabian Eagle to establish CoMira Diagnostics and localize its Co-Dx PCR ...

Lucid Diagnostics’ flagship offerings are the EsoGuard and EsoCheck tests for non-endoscopic detection of Barrett’s esophagus and early esophageal adenocarcinoma. However, its adoption rate remains ...

Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will respond to certain therapies and doses. The company said its test will span ...

Corewell Health has signed on to a joint venture with Quest Diagnostics covering inpatient and outpatient lab management and the construction of a new 100,000-square-foot advanced lab facility. The ...

Tesla is possibly the only car company in the world that offers free service manuals and easy access to its proprietary diagnostics software. The latter is called Tesla Toolbox, and anyone can buy a ...

It seems there’s fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon.

(Reuters) -Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing ...

People are usually skeptical about putting premature technology over human judgment, but more than any other industry, science prevails in healthcare. AI may well still be in its infancy, but its ...